These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5457 related articles for article (PubMed ID: 3540619)

  • 1. The anti-melanoma activity of inulin in mice.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):903-8. PubMed ID: 3540619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):895-901. PubMed ID: 3796631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvanticity of gamma inulin.
    Cooper PD; Steele EJ
    Immunol Cell Biol; 1988; 66 ( Pt 5-6)():345-52. PubMed ID: 3265692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms.
    Kakuta S; Tagawa Y; Shibata S; Nanno M; Iwakura Y
    Immunology; 2002 Jan; 105(1):92-100. PubMed ID: 11849319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A; Cameron RB; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein A treatment of cancer: activation of a serum component with trans-species anti-B16 melanoma activity.
    Cooper PD; Masinello GR
    Int J Cancer; 1983 Dec; 32(6):737-44. PubMed ID: 6606628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
    Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
    Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
    Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
    Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM
    J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.
    DeMatos P; Abdel-Wahab Z; Vervaert C; Hester D; Seigler H
    J Surg Oncol; 1998 Jun; 68(2):79-91. PubMed ID: 9624036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction and mechanism study of anti-melanoma immune response by M. tuberculosis Ag85B].
    Wu XZ; Wei HM; Zheng XD; Jin TC; Tian ZG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):36-8. PubMed ID: 17210103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells.
    Kerekes K; Cooper PD; Prechl J; Józsi M; Bajtay Z; Erdei A
    J Leukoc Biol; 2001 Jan; 69(1):69-74. PubMed ID: 11200070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.
    Kurosawa S; Harada M; Matsuzaki G; Shinomiya Y; Terao H; Kobayashi N; Nomoto K
    Immunology; 1995 Jun; 85(2):338-46. PubMed ID: 7642226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
    Dezfouli S; Hatzinisiriou I; Ralph SJ
    Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autolymphocyte therapy. III. Effective adjuvant adoptive cellular therapy with in vivo anti-tumor specificity against murine melanoma and carcinoma using ex-vivo-activated memory T-lymphocytes.
    Gold JE; Masters TR; Osband ME
    J Surg Res; 1995 Aug; 59(2):279-86. PubMed ID: 7543632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
    Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
    Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 273.